Pittcon Q&A

February 28, 2015

Extracts from Laboratory Equipment:

Pittcon Q&A

Ahead of Pittcon 2015 in New Orleans, Editor-in-Chief Michelle Taylor spoke with experts from exhibiting companies to get their take on what to expect at both this year’s Pittcon as well as future Pittcons.

What technologies and trends do you expect to see at Pittcon 2015?

“I believe that the world of analytical (and medical) science is on a journey from analysis in the laboratory to measurement at the point of sample - and I hope that this year’s Pittcon will reflect that trend.” - Stephen Tomisich, Director and CEO, Trajan Scientific and Medical

What technologies and trends do you expect to see beyond 2015?

“Looking ahead, I expect to see more companies presenting portable instruments and the easy-to-use computing and consumable formats that this analytical shift demands.” - Stephen Tomisich, Director and CEO, Trajan Scientific and Medical

Taylor also asked our Q&A interview subjects to sum up the future of the lab industry in a few words.

Here's what they said:

“Powerful, affordable, portable analysis” - Stephen Tomisich

Read the full article at the Laboratory Equipment website.

Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.